MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Twist Bioscience Corporation (NASDAQ: TWST)
Organization & Developments: Twist Bioscience
Parents
Twist Bioscience Corporation (NASDAQ: TWST)
Children
*Twist Bioscience manufactures synthetic DNA for clients in the biotechnology industry.
*Twist Bioscience, whose disruptive platform manufactures synthetic DNA by “writing” DNA on a silicon chip, joined Illumina, Microsoft, and data storage giant Western Digital to co-lead the DNA Data Storage Alliance.
2020: Takeda teams up with Twist Bioscience to boost biologics R&D
2020: Twist Bioscience: Growth Play In Synthetic Biology
2022: Twist Bioscience Corporation 2022 Q4 - Results - Earnings Call Presentation_seekingalpha.com
2022: Twist Bioscience: A First Take_seekingalpha.com
2022: Twist Bioscience: Cash Burn Continues To Be The Issue_ seekingalpha.com
2022: Twist Bioscience: DNA Synthesis Leader Appealing 'Picks And Shovels' Play_seekingalpha.com
2023: A New Look At Twist Bioscience (NASDAQ:TWST)
2023: Reconsidering Twist Biosciences (NASDAQ:TWST)
2023: Twist Bioscience cuts a quarter of workforce amid record-high revenues
2023: Twist Bioscience: Continued Progress Despite Headwinds_ seekingalpha.com
2024: Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
2024: Absci and Twist Bioscience Team Up to Redefine Antibody Discovery with AI
2024: Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
2024: Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now
2024: Twist Bioscience Corporation 2024 Q1 - Results - Earnings Call Presentation
2024: Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
2024: Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
2024: Twist Bioscience: A 'Hold' In DNA Data Storage
2024: Twist Bioscience: A Post-Earnings Assessment_seekingalpha.com
2024: Twist Bioscience: Growing Customer Base And Technology Platform Make Me Like This Stock_seekingalpha.com
2024: Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)_ seekingalpha
2024: Twist Bioscience: Market Jitters Could Create A Buying Opportunity
2024: Twist Bioscience: Path To Profitability Beginning To Take Shape_ seekingalpha.com
2024: Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'
2024: Twist Bioscience's SWOT analysis: DNA storage innovation propels stock outlook
2025: Twist Bioscience: Expansion Efforts Continue To Face Challenges
2025: Twist Bioscience: Valuation Is Weighing On The Stock
Jumps
Finance & Acquisitions: Twist Bioscience
Key People: Twist Bioscience